Related Experiment Video
Updated: Oct 4, 2025

07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.2K
Summary
Epilepsy in pregnancy requires careful management. While some antiseizure drugs carry risks, others like lamotrigine and levetiracetam are safer, and breastfeeding is encouraged for women with epilepsy.
Area of Science:
- Neurology
- Obstetrics
- Pharmacology
Background:
- Seizure disorders, primarily epilepsy, are the most common major neurologic complication during pregnancy.
- Approximately 0.3% to 0.8% of all gestations are affected by epilepsy.
- Women of childbearing age with epilepsy necessitate specialized prenatal care.
Purpose of the Study:
- To offer current information for healthcare providers managing epilepsy during pregnancy.
- To guide practitioners in the care of pregnant women with epilepsy.
Main Methods:
- Review of ongoing multicenter pregnancy registries and studies.
- Analysis of data on antiseizure medications (ASMs) and their risks.
- Evaluation of fertility rates, folic acid supplementation, and breastfeeding in women with epilepsy.
Main Results:
- Valproate is associated with significant risks of malformations and cognitive/behavioral issues.
- Lamotrigine and levetiracetam present lower risks, but risks for many ASMs remain unclear.
- Folic acid supplementation ( > 400 mcg/d) in early pregnancy improves neurodevelopmental outcomes; breastfeeding is safe and recommended.
Conclusions:
- Early and regular counseling on reproductive health is crucial for women with epilepsy.
- Practitioners must discuss obstetric risks, teratogenicity, neurodevelopmental effects of ASMs, and a comprehensive care plan.
- Most pregnancies in women with epilepsy are uneventful, and reassurance is important.
Related Concept Videos
Epilepsy and Seizures: Overview
337
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
337
Seizures: Classification
648
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
648
Antiepileptic Drugs: Potassium Channel Activators
323
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
323
Antiepileptic Drugs: Sodium Channel Blockers
1.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators
763
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
763
Antiepileptic Drugs: Glutamate Antagonists
564
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
564

